New heart device tested in everyday use to seal birth defects
NCT ID NCT05887700
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is tracking 145 people who have a hole in their heart (atrial septal defect) and received the CeraFlex closure device. Researchers want to see how well the device works in real-world settings, focusing on safety and successful closure of the hole at 6 months. The device is implanted through a tube in a blood vessel, avoiding open-heart surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CeraFlex ASD closure device (a heart implant that closes a hole in the heart wall)
What this could lead to
If successful, this registry could confirm that the CeraFlex device is a safe and effective option for closing atrial septal defects without open-heart surgery.
What could go wrong
This is an observational registry, not a controlled trial, so results may be less definitive. Risks include device-related complications like stroke, embolization, or residual shunts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL SEPTAL DEFECT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HCOR - Associação Beneficente Síria
RECRUITINGSão Paulo, Brazil
Contact
-
Hospital Beneficência Portuguesa
RECRUITINGSão Paulo, Brazil
Contact
-
Hospital Pequeno Príncipe
RECRUITINGCuritiba, Brazil
Contact
-
Onassis Cardiac Surgery Center
RECRUITINGKallithea, Greece
Contact
Contact
-
Santa Casa de Misericórdia de Porto Alegre
RECRUITINGPorto Alegre, Brazil
Contact